Publications To Date


    Filter Publications

    PAGE 62 OF 87 | DISPLAYING 916 - 930 OF 1293 RESULTS

    Cubasch H. et al., South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment., [Epub ahead of print]., J. Global Oncology, Jun 22, 2016

    Makhlouf A-M. et al., Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma., , Oncotarget, Jun 18, 2016

    Vatsveen T.K. et al., VOLIN and KJON – Two Novel Hyperdiploid Myeloma Cell Line., [Epub ahead of print]., Genes, Chromosomes, Cancer., Jun 16, 2016

    Nazarian J. et al., Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report., [Epub ahead of print]., Oncotarget, Jun 14, 2016

    Mullane S.A. et. al., Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma., [Epub ahead of print]., Sci. Reports, Jun 10, 2016

    Tiedje V. et al., Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients., [Epub ahead of print]., Eur. J. Endocrinology, Jun 09, 2016

    Prat A. et al., Prognostic Value of Intrinsic Subtypes in Hormone Receptor–Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib., [Epub ahead of print]., JAMA Oncology, Jun 09, 2016

    Curigliano G. et al., Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study., [Epub ahead of print]., The Breast, Jun 07, 2016

    Ramberg H. et al., PBX3 is a putative biomarker of aggressive Prostate Cancer., [Epub ahead of print]., Int. J. Cancer, Jun 07, 2016

    Zhang M. et al., Identification of New Biomarkers Associated With IDH Mutation and Prognosis in Astrocytic Tumors Using NanoString nCounter Analysis System., [Epub ahead of print]., Appl Immunohistochem Mol Morphol., Jun 02, 2016

    Shen F. et al., Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells, 10.1158/1541-7786.MCR-16-0013 , Mol. Cancer Res., Jun 01, 2016

    Mineo M. et al., The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches., [Epub ahead of print]., Cell Reports, Jun 01, 2016

    Zhang J. et al., A Fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in female cancer cell lines., [Epub ahead of print]., BMC. Complementary and Alternative Medicine, May 28, 2016

    Seiwert T.Y. et al., Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial., [Epub ahead of print]., The Lancet Oncology, May 27, 2016

    Urup T. et al., Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients., [Epub ahead of print]., Molecular Oncology, May 26, 2016